These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 9453250

  • 1. 9-Nitrocamptothecin inhibits tumor recrosis factor-mediated activation of human immunodeficiency virus type 1 and enhances apoptosis in a latently infected T cell clone.
    Moulton S, Pantazis P, Epstein JS, Sadaie MR.
    AIDS Res Hum Retroviruses; 1998 Jan 01; 14(1):39-49. PubMed ID: 9453250
    [Abstract] [Full Text] [Related]

  • 2. 9-nitrocamptothecin selectively inhibits human immunodeficiency virus type 1 replication in freshly infected parental but not 9-nitrocamptothecin-resistant U937 monocytoid cells.
    Sadaie MR, Doniger J, Hung CL, Pantazis P.
    AIDS Res Hum Retroviruses; 1999 Feb 10; 15(3):239-45. PubMed ID: 10052754
    [Abstract] [Full Text] [Related]

  • 3. 9-Nitrocamptothecin inhibits HIV-1 replication in human peripheral blood lymphocytes: a potential alternative for HIV-infection/AIDS therapy.
    Hung CL, Doniger J, Palini A, Snyder SW, Radonovich MF, Brady JN, Pantazis P, Sadaie MR.
    J Med Virol; 2001 Jul 10; 64(3):238-44. PubMed ID: 11424110
    [Abstract] [Full Text] [Related]

  • 4. Camptothecin and 9-nitrocamptothecin (9NC) as anti-cancer, anti-HIV and cell-differentiation agents. Development of resistance, enhancement of 9NC-induced activities and combination treatments in cell and animal models.
    Pantazis P, Han Z, Balan K, Wang Y, Wyche JH.
    Anticancer Res; 2003 Jul 10; 23(5A):3623-38. PubMed ID: 14666658
    [Abstract] [Full Text] [Related]

  • 5. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
    Popik W, Pitha PM.
    Virology; 1994 Aug 01; 202(2):521-9. PubMed ID: 8030218
    [Abstract] [Full Text] [Related]

  • 6. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
    Chatterjee D, Schmitz I, Krueger A, Yeung K, Kirchhoff S, Krammer PH, Peter ME, Wyche JH, Pantazis P.
    Cancer Res; 2001 Oct 01; 61(19):7148-54. PubMed ID: 11585748
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells.
    Rabbi MF, Finnegan A, Al-Harthi L, Song S, Roebuck KA.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec 01; 19(4):321-31. PubMed ID: 9833740
    [Abstract] [Full Text] [Related]

  • 8. Induction of senescent cell-derived inhibitor of DNA synthesis gene, SDI1, in hepatoblastoma (HepG2) cells arrested in the G2-phase of the cell cycle by 9-nitrocamptothecin.
    Khaoustov VI, Ozer A, Smith JR, Noda A, Mearns M, Krishnan B, Slagle BL, Yoffe B.
    Lab Invest; 1995 Jul 01; 73(1):118-27. PubMed ID: 7603034
    [Abstract] [Full Text] [Related]

  • 9. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage.
    Finnegan A, Roebuck KA, Nakai BE, Gu DS, Rabbi MF, Song S, Landay AL.
    J Immunol; 1996 Jan 15; 156(2):841-51. PubMed ID: 8543841
    [Abstract] [Full Text] [Related]

  • 10. Rapid and sensitive detection of cell-associated HIV-1 in latently infected cell lines and in patient cells using sodium-n-butyrate induction and RT-PCR.
    Kashanchi F, Melpolder JC, Epstein JS, Sadaie MR.
    J Med Virol; 1997 Jun 15; 52(2):179-89. PubMed ID: 9179766
    [Abstract] [Full Text] [Related]

  • 11. Host cell gene expression during human immunodeficiency virus type 1 latency and reactivation and effects of targeting genes that are differentially expressed in viral latency.
    Krishnan V, Zeichner SL.
    J Virol; 2004 Sep 15; 78(17):9458-73. PubMed ID: 15308739
    [Abstract] [Full Text] [Related]

  • 12. Substance P enhances HIV-1 replication in latently infected human immune cells.
    Li Y, Douglas SD, Song L, Sun S, Ho WZ.
    J Neuroimmunol; 2001 Dec 03; 121(1-2):67-75. PubMed ID: 11730941
    [Abstract] [Full Text] [Related]

  • 13. Reduction of 9-nitrocamptothecin-triggered apoptosis in DU-145 human prostate cancer cells by ectopic expression of 14-3-3zeta.
    Chatterjee D, Goldman M, Braastad CD, Darnowski J, Wyche JH, Pantazis P, Goodglick L.
    Int J Oncol; 2004 Aug 03; 25(2):503-9. PubMed ID: 15254750
    [Abstract] [Full Text] [Related]

  • 14. Characterization of 9-nitrocamptothecin liposomes: anticancer properties and mechanisms on hepatocellular carcinoma in vitro and in vivo.
    Zheng S, Chang S, Lu J, Chen Z, Xie L, Nie Y, He B, Zou S, Gu Z.
    PLoS One; 2011 Aug 03; 6(6):e21064. PubMed ID: 21695227
    [Abstract] [Full Text] [Related]

  • 15. Cytotoxic efficacy of 9-nitrocamptothecin in the treatment of human malignant melanoma cells in vitro.
    Pantazis P, Early JA, Mendoza JT, DeJesus AR, Giovanella BC.
    Cancer Res; 1994 Feb 01; 54(3):771-6. PubMed ID: 8306340
    [Abstract] [Full Text] [Related]

  • 16. Acquisition of cellular resistance to 9-nitro-camptothecin correlates with suppression of transcription factor NF-kappa B activation and potentiation of cytotoxicity by tumor necrosis factor in human histiocytic lymphoma U-937 cells.
    Singh S, Raju U, Mendoza J, Pantazis P, Aggarwal BB.
    Anticancer Drugs; 1998 Sep 01; 9(8):703-14. PubMed ID: 9823429
    [Abstract] [Full Text] [Related]

  • 17. The presence of tat protein or tumor necrosis factor alpha is critical for herpes simplex virus type 1-induced expression of human immunodeficiency virus type 1.
    Popik W, Pitha PM.
    J Virol; 1994 Mar 01; 68(3):1324-33. PubMed ID: 8107197
    [Abstract] [Full Text] [Related]

  • 18. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD, Moore B, Cloyd MW.
    Virology; 1996 Nov 01; 225(1):196-212. PubMed ID: 8918547
    [Abstract] [Full Text] [Related]

  • 19. The thalidomide analogue CC-3052 inhibits HIV-1 and tumour necrosis factor-alpha (TNF-alpha) expression in acutely and chronically infected cells in vitro.
    La Maestra L, Zaninoni A, Marriott JB, Lazzarin A, Dalgleish AG, Barcellini W.
    Clin Exp Immunol; 2000 Jan 01; 119(1):123-9. PubMed ID: 10606973
    [Abstract] [Full Text] [Related]

  • 20. Infection of human macrophages with an endogenous tumour necrosis factor-alpha (TNF-alpha)-independent human immunodeficiency virus type 1 isolate is unresponsive to the TNF-alpha synthesis inhibitor RP 55778.
    Le Naour R, Clayette P, Henin Y, Mabondzo A, Raoul H, Bousseau A, Dormont D.
    J Gen Virol; 1994 Jun 01; 75 ( Pt 6)():1379-88. PubMed ID: 7515938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.